Generics Bulletin is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dierks follows Walz as NuPharm’s chief

Executive Summary

NuPharm has appointed former Meda chief executive officer (CEO) Jörg-Thomas Dierks to become CEO of the European central nervous system (CNS) specialist, replacing with immediate effect Stephan Walz, who has “decided to step down in order to pursue other activities”.

You may also be interested in...



Neuraxpharm Names Local Head As It Expands Into UK

Neuraxpharm has appointed Craig Bowen as general manager of its UK affiliate at the same time as the European central nervous system specialist has launched its first products in the UK market.

German HTA Negative On Benefits Of First Ever Peanut Allergy Treatment

The decision by IQWiG could have an impact on how Palforzia is priced if the findings are upheld.

Lupin Expects Exeltis Partnership To Boost Solosec

Lupin is hoping that a newly-struck partnership with women’s health specialist Exeltis will improve the fortunes of its Solosec (secnidazole) bacterial vaginosis and trichomoniasis treatment in the US.

Topics

UsernamePublicRestriction

Register

GB001196

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel